COVID-19
Conditions
Brief summary
The goal of this study is to reduce morbidity and mortality from COVID-19 amongst people who are detained in and work in correctional facilities. The overall objective is to identify feasible and effective interventions to improve vaccine uptake in correctional facilities and study the effectiveness of these interventions through rapid cycle, cluster randomized trials in the Pennsylvania prison system.
Detailed description
Aim 1: To identify correctional system strategies to address COVID-19 and influenza vaccine acceptance amongst incarcerated people and correctional staff. Aim 2: To select feasible strategies for a statewide correctional system at the patient-, provider-, practice- and prison-level to address COVID-19 and influenza vaccine uptake through a community engaged research approach. Aim 3: To compare the effectiveness of interventions to address COVID-19 and influenza vaccine acceptance using a rapid cycle cluster randomized trial design in prison. This study is highly innovative in its application of rapid cycle, cluster randomized trials in correctional systems to test the effectiveness of strategies identified using a community based participatory research approach. The results will serve as an evidence base for improving vaccine uptake that can be scaled nationally and adapted for other populations affected by the criminal legal system.
Interventions
BEHAVIORALADVANCE Steering Committee interventions
Interventions will be selected by the ADVANCE Steering Committee and will be rapidly deployed without additional effort on the part of front-line staff at four distinct levels: patient, provider, practice and prison level. Interventions will be tested one at a time in an iterative process. A participatory, assets-based framework will be used to identify acceptable and feasible strategies to improve vaccine acceptance. Each round of testing will include 1 month of preparation by the steering committee,12-week intervention period, and 2 months for analysis and rapid dissemination.
Sponsors
National Institute on Minority Health and Health Disparities (NIMHD)
Yale University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Intervention model description
Rapid cycle cluster randomized controlled trial (RCT). Randomization will occur at different levels, depending on the intervention that is being tested. Interviews: 14 key informant interviews will be conducted within each state correctional system that is identified as high performing (high vaccination rates for staff and incarcerated individuals). For rapid RCT: Pennsylvania Department Of Corrections operates 23 prisons which incarcerate approximately 35000 men and 1800 women. Every incarcerated individual in a PA prison is a potential candidate for the rapid RCT.
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* All incarcerated people in the Pennsylvania DOC are included in the study population for these low risk interventions. In this each individual intervention, inclusion criteria will be based on where incarcerated people are housed and therefore what intervention they will be exposed to.
Exclusion criteria
*
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| COVID-19 vaccine acceptance rate | up to 12 weeks post intervention | COVID-19 vaccine acceptance rate amongst incarcerated people and correctional staff assessed as the number of participants that receive a COVID-19 vaccine dose or complete the COVID-19 vaccine series by electronic health record (EHR) or self report. This will apply to anyone not fully up-to-date with the full immunization series, which is defined as inclusive of boosters. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Hospitalization Rate | up to 12 weeks post intervention | Total number of new admissions for COVID-19 infections by EHR or self report. |
| Deaths | up to 12 weeks | Number of deaths from COVID-19 infections by EHR |
| COVID-19 infections | up to 12 weeks post intervention | Number of participants with COVID-19 infections by EHR or self report. |
| Vaccine refusal rate | up to 12 weeks post intervention | Vaccine refusal rate assessed by number of vaccines refused/total number fully vaccinated at start of the intervention |
| Vaccine acceptance rate | up to 12 weeks post intervention | Vaccine acceptance rate assessed by number of vaccines administered/total number fully vaccinated at start of the intervention |
| Change in vaccination for other respiratory outbreaks | up to 12 weeks | Change in vaccination rates for other respiratory outbreaks during winter season including influenza vaccine |
Countries
United States
Contacts
Primary ContactLisa B Puglisi, MD
Outcome results
None listed